NASDAQ (usa) | 6715.56 | -12.11 | -0.18% | |
FTSE 100 (london) | 7487.96 | -5.12 | -0.07% | |
DAX (german) | 13465.51 | 235.94 | 1.78% | |
NIKKEI 225 (japan) | 22420.08 | 408.47 | 1.86% | |
Hang - Seng (hong kong) | 28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) | 3391.61 | 17.53 | 0.52% | |
KOSPI (korea) | 2556.47 | 33.04 | 1.31% | |
All Ordinaries (australia) | 6005.30 | 28.90 | 0.48% | |
BOVESPA (brazil) | 74092.76 | -215.73 | -0.29% |
Expleo Solutions Limited (NSE: EXPLEOSOL)
EXPLEOSOL Technical Analysis
4
As on 26th Apr 2024 EXPLEOSOL SHARE Price closed @ 1302.15 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 1402.91 & Sell for SHORT-TERM with Stoploss of 1321.88 we also expect STOCK to react on Following IMPORTANT LEVELS. |
EXPLEOSOLSHARE Price
Open | 1307.00 | Change | Price | % |
High | 1325.90 | 1 Day | -4.85 | -0.37 |
Low | 1299.10 | 1 Week | -26.10 | -1.96 |
Close | 1302.15 | 1 Month | 65.90 | 5.33 |
Volume | 13373 | 1 Year | 12.90 | 1.00 |
52 Week High 1740.25 | 52 Week Low 1161.15 |
NSE INDIA Most Active Stocks
IDEA | 14.00 | 0.72% |
YESBANK | 26.15 | 0.77% |
IRFC | 158.05 | 5.19% |
GMRINFRA | 90.75 | 6.58% |
HUDCO | 228.10 | 12.34% |
MAHABANK | 67.65 | 3.68% |
SAIL | 168.55 | 2.18% |
NHPC | 92.55 | 1.65% |
TATASTEEL | 165.80 | -1.13% |
IDFCFIRSTB | 84.80 | 1.68% |
NSE INDIA Top Gainers Stocks
ROSSELLIND | 468.35 | 20.00% |
MGEL | 23.25 | 19.85% |
KIRLOSIND | 5232.65 | 12.84% |
HUDCO | 228.10 | 12.34% |
DPABHUSHAN | 1133.45 | 10.42% |
KECL | 130.60 | 10.30% |
EXCEL | 0.55 | 10.00% |
ACL | 98.15 | 9.79% |
ACL | 98.15 | 9.79% |
ACL | 98.15 | 9.79% |
NSE INDIA Top Losers Stocks
LTTS | 4778.10 | -7.81% |
BAJFINANCE | 6731.20 | -7.73% |
DBSTOCKBRO | 50.90 | -5.91% |
COMPUSOFT | 33.95 | -5.56% |
KSB | 4674.75 | -5.21% |
KSB | 4674.75 | -5.21% |
KSB | 4674.75 | -5.21% |
KSB | 4674.75 | -5.21% |
KSB | 4674.75 | -5.21% |
KSB | 4674.75 | -5.21% |
EXPLEOSOL Daily Charts |
EXPLEOSOL Intraday Charts |
Whats New @ Bazaartrend |
EXPLEOSOL Free Analysis |
|
EXPLEOSOL Important Levels Intraday
RESISTANCE | 1353.79 |
RESISTANCE | 1337.23 |
RESISTANCE | 1326.99 |
RESISTANCE | 1316.76 |
SUPPORT | 1287.54 |
SUPPORT | 1277.31 |
SUPPORT | 1267.07 |
SUPPORT | 1250.51 |
EXPLEOSOL Target April 2024
4th UP Target | 1791.39 |
3rd UP Target | 1650.36 |
2nd UP Target | 1563.19 |
1st UP Target | 1476.02 |
1st DOWN Target | 1227.28 |
2nd DOWN Target | 1140.11 |
3rd DOWN Target | 1052.94 |
4th DOWN Target | 911.91 |
EXPLEOSOL Weekly Target
4th UP Target | 1461.12 |
3rd UP Target | 1418.51 |
2nd UP Target | 1392.17 |
1st UP Target | 1365.83 |
1st DOWN Target | 1290.67 |
2nd DOWN Target | 1264.33 |
3rd DOWN Target | 1237.99 |
4th DOWN Target | 1195.38 |
EXPLEOSOL Target2024
4th UP Target | 2505.64 |
3rd UP Target | 2118.65 |
2nd UP Target | 1879.44 |
1st UP Target | 1640.23 |
1st DOWN Target | 957.67 |
2nd DOWN Target | 718.46 |
3rd DOWN Target | 479.25 |
4th DOWN Target | 92.26 |
Expleo Solutions Limited ( NSE INDIA Symbol : EXPLEOSOL )
Sector : Technology And Other Stocks in Same Sector
Sector : Technology And Other Stocks in Same Sector
EXPLEOSOL Synopsis Technicals View
50 Day EMA |
Close is Above EMA 50 (Short Term) |
Bullish | |
100 Day EMA | Close is Above EMA 100 (Mid Term) | Bullish | |
200 Day EMA | Close is Above EMA 200 (Long Term) | Bullish | |
MACD (12 26 9) | MACD Line is Less Then SIGNAL Line | Bearish | |
RSI (14) | RSI is Below 30 | Over Sold | |
MFI (14) | MFI is Below 20 | Over Sold | |
CCI (20) | CCI is Below -100 | Over Sold | |
WILLIAM %R (14) | William %R is Below -80 | Over Sold | |
ADX (14) | ADX is Above 20 & +DI is Below -DI | Down Trend | |
PSAR | Stoploss For Long Buy | 229.90 | |
10 Day Avg Volume | Traded 5.81 % More then 10 Day Average Volume |
EXPLEOSOL Other Details
Segment | BE | |
Market Capital | 11771408384.00 | |
Sector | Technology | |
Industry | Information Technology Services | |
Offical website | > echo $website ; ?> |
EXPLEOSOL Address
EXPLEOSOL Latest News
EXPLEOSOL Business Profile
Expleo Solutions Limited, together with its subsidiaries, primarily provides software validation and verification services to the banking, financial services, and insurance industries worldwide. The company offers quality engineering, quality management, software testing, DevOps, and test automation services. The company was formerly known as SQS India BFSI Limited and changed its name to Expleo Solutions Limited in April 2019. Expleo Solutions Limited was incorporated in 1998 and is based in Chennai, India. Expleo Solutions Limited Limited is a subsidiary of Expleo Technology Germany GmbH. Address: 6A, Prince Infocity II, Chennai, India, 600096
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service